Physician profile
Anna N Rinewalt
NPI 1720289945
$6,969.35
in general payments reported to CMS, 2019-2025
22 companies · $3,352 in 2025
The $3,352 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $153 · 2021: $3,098 · 2022: $102 · 2023: $68.26 · 2024: $63.32 · 2025: $3,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,239 · Food and Beverage: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,239.00 |
| Food and Beverage | $1,244.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Spine, LLC | $3,000.00 | 2021 | |
| Spinefrontier, INC. | $1,037.74 | 2025 | Facetfuse, Nanofuse, Sijfuse |
| Globus Medical, INC. | $1,017.02 | 2025 | Senza, Vyrsa V1 |
| Stryker Corporation | $952.77 | 2025 | Mild Device Kit |
| Boston Scientific Corporation | $233.63 | 2025 | Intracept, Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $99.36 | 2019-2020 | |
| Xtant Medical INC | $92.79 | 2025 | |
| Medtronic, INC. | $88.04 | 2021-2023 | Intellis Adaptivestim |
| Avita Medical Americas, LLC | $66.32 | 2019 | |
| Allergan, INC. | $52.85 | 2020-2022 | |
| Nalu Medical, INC. | $44.42 | 2022-2024 | Nalu Neurostimulation System |
| Biodelivery Sciences International, INC. | $43.04 | 2020 | |
| Abbvie INC. | $39.36 | 2022 | |
| Bioventus LLC | $37.58 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $35.27 | 2024-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $34.45 | 2023 | Zilretta, Iovera, Exparel |
| Arbor Pharmaceuticals, INC. | $22.65 | 2019-2021 | |
| Si-Bone, INC. | $19.34 | 2024 | |
| Nevro Corp. | $19.15 | 2020 | |
| Smith+Nephew, INC. | $13.21 | 2021 | |
| Lilly USA, LLC | $12.56 | 2019 | |
| Vgi Medical, LLC | $7.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Rinewalt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.